Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,135 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07860645Recruiting
Lifestyle program for menopause symptoms and sleep
This study tests whether a lifestyle program can help women in perimenopause or postmenopause feel better by reducing symptoms like hot flashes, sleep problems, and anxiety. If you join, you'll get support and be followed for 24 weeks to see if the program improves your quality of life.
Konya, KonyaAges 40–55 - NCT07844460Recruiting
3D MRE imaging study for vestibular schwannoma
This study uses a special MRI technique called 3D MRE to look at the physical properties of vestibular schwannoma tumors (non-cancerous growths on the hearing and balance nerve) before surgery. The goal is to see if these properties can predict the tumor's features, which might help doctors plan better.
Shenyang, LiaoningAges 18–75 - NCT07403331Recruiting
Nerve pain in legs: spinal cord stimulation plus team care
This trial tests a treatment bundle that combines a spinal cord stimulator (a device that sends mild electrical pulses to your spine to block pain signals) with a team of specialists (like a psychologist and physical therapist) to reduce chronic nerve pain in the legs and improve your ability to move and function.
OsloAges 18–60 - NCT06430736RecruitingPhase 2
Tocilizumab before or during CAR-T therapy
This study tests whether giving tocilizumab (a drug that calms inflammation) before CAR-T cell therapy helps prevent side effects. It compares using it ahead of time versus only when needed. You may be eligible if you are scheduled for CAR-T therapy for lymphoma, leukemia, or myeloma.
Bern, Canton of BernAges 18 years+ - NCT07162506RecruitingPhase 2
Chemo-immunotherapy then surgery or radiation for esophageal cancer
This trial compares two standard treatments for esophageal cancer that has responded to initial chemo-immunotherapy: surgery to remove the tumor or radiation combined with chemotherapy. The goal is to see which approach offers better outcomes and quality of life.
Tianjin, Tianjin MunicipalityAges 18–75 - NCT07786233Recruiting
Healthy brain scan images for Chinese volunteers
This study creates a detailed map of healthy brains from Chinese volunteers to help doctors better understand normal brain structure. If you are a healthy adult, your participation may assist future medical research and care.
Xi'an, ShaanxiAges 16–66 - NCT07760012Recruiting
Pet scan with new tracer for solid tumors
This study uses a new imaging tracer, called 68Ga-SorB, during a PET/CT scan to look at tumors. It may help doctors see cancer more clearly. The trial is for adults with certain types of solid tumors (such as melanoma, liver, lung, breast, pancreatic, ovarian, or bile duct cancer) who need a PET/CT scan as part of their care.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07141251Recruiting
Custom stent-graft procedure for complex aortic aneurysm repair
This study tests a new way to repair a complex aortic aneurysm (a bulge in the main artery) using a special procedure that helps keep blood flowing to your vital organs. It may help people who are not candidates for standard surgery. The goal is to see if this approach is safe and works well.
Beijing, Beijing MunicipalityAges 18–80 - NCT07875829Recruiting
Recovery after colorectal surgery: Robots vs laparoscopic
This study compares how quickly and how well people recover after surgery to remove part of the colon or rectum, using either a robotic or a laparoscopic (keyhole) approach. Both are minimally invasive, but this trial aims to see if one leads to a smoother and faster recovery.
Funchal, MadeiraAges 18 years+ - NCT05805007RecruitingEarly Phase 1
Gene editing treatment for retinitis pigmentosa
This study tests a gene-editing drug, ZVS203e, injected into one eye to see if it is safe and tolerable for people with retinitis pigmentosa caused by a specific genetic change in the RHO gene. It may help slow vision loss or improve vision, but the main goal is to check safety.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07874542Recruiting
Blood test to help classify kidney masses before surgery
This study looks at whether a simple blood test can help doctors tell if a kidney mass is cancer before surgery. It aims to improve how kidney masses are classified and guide treatment decisions.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07876154RecruitingPhase 2
Immunotherapy plus chemo before surgery for locally advanced cervical cancer
This trial tests a new combination of two immunotherapy drugs with standard chemotherapy before surgery for cervical cancer that has not spread far. The goal is to shrink the tumor and improve treatment outcomes.
Xi'an, ShaanxiAges 18–70 - NCT07562932Recruiting
Norepinephrine vs dopamine for cardiogenic shock
This study compares two blood pressure support medicines (norepinephrine and dopamine) in adults with cardiogenic shock, a condition where the heart cannot pump enough blood. It aims to find which medicine works better for patients with this severe heart condition.
Gwangju, Jeollanam-doAges 19 years+ - NCT06691217RecruitingPhase 2
Study of a new drug to reduce blood vessel swelling in TET2 mutations
This study tests an investigational drug that may reduce swelling (inflammation) inside the blood vessels of people with heart disease and a specific gene change called TET2. This gene change is linked to higher inflammation and heart risks, and the drug aims to lower that risk.
Boston, MassachusettsAges 18 years+ - NCT07846878Recruiting
Predicting pain after orthopedic surgery
This study tests a tool that doctors can use before surgery to predict whether you might have longer-lasting pain after bone or joint surgery. Knowing this in advance could help your care team plan better pain relief for you.
ChongqingAges 18–90 - NCT07159204RecruitingPhase 2
A trial testing a chemo plus immunotherapy combo for biliary tract cancer
This trial tests a combination of a special form of chemotherapy (paclitaxel micelle) and an immunotherapy for people with advanced biliary tract cancer (cancer of the bile ducts or gallbladder) that has not responded to or stopped working after first treatment. The goal is to see if this combination can help shrink or control the cancer.
Beijing, Beijing MunicipalityAges 18–74 - NCT07875595Recruiting
Immune markers for predicting problems after liver transplant
This study looks at blood markers of the immune system to see if they can predict complications after a liver transplant. It aims to help doctors personalize care and catch problems early.
Pilar, Buenos AiresAges 18 years+ - NCT07875959Recruiting
PET scan to see kidney tumors
This trial tests a new type of PET scan to better see kidney tumors. It may help doctors understand the tumor better before biopsy or surgery.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07876570Recruiting
Predicting memory decline with brain and blood tests
This study follows older adults with normal memory, mild memory problems, or dementia over a year to see if brain scans and blood tests can predict who will get worse. It may help find early warning signs of Alzheimer's and other dementias.
Beijing, Beijing MunicipalityAges 50 years+ - NCT07125950RecruitingPhase 2
SHR2554 plus hormone therapy for advanced breast cancer
This trial tests a new drug (SHR2554) combined with standard hormone therapy for people with advanced or metastatic breast cancer. The goal is to see if the combination helps control the cancer better.
Zhengzhou, HenanAges 18 years+ - NCT07298824RecruitingPhase 2
MR-61 eye drops for slowing nearsightedness in children
This trial tests an eye drop called MR-61 to see if it can slow down worsening nearsightedness (myopia) in children and teens. The study aims to find a safe and easy way to keep their vision from getting worse.
Nanchang, JiangxiAges 3–18 - NCT07876479Recruiting
Comparing kidney nerve treatment times for high blood pressure
This study tests whether the length of time used for a kidney nerve treatment (renal denervation) affects how well it lowers blood pressure. It may help people whose blood pressure is still high despite taking medications.
ShanghaiAges 20–80 - NCT07874581Recruiting
Study of MRG003 for small cell lung cancer that has returned
This study tests a new drug, MRG003, for people with a type of lung cancer called small cell lung cancer that has spread or come back after earlier treatment. The goal is to see if this drug can help shrink tumors or slow the cancer's growth.
ShanghaiAges 18 years+ - NCT07708246Recruiting
Parent-led social skills training for children with autism
This study teaches parents to run play-based activities at home that help children with autism improve social skills. Parents attend one training session and get monthly video check-ins, and the program runs for 6 months.
Shanghai, Shanghai MunicipalityAges 3–10
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,135 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.